TAVR (TAVI)

Video

THVGreece 2026 | Tricuspid Valve

August 6, 2026 | Evangelos Leontiadis…

This session features leading surgeons discussing the tricuspid valve at the Transcatheter Heart Valves Greece (THVGreece) 2026 conference. Moderators Vassilis Voudris, Director of the Cardiology/Interventional Cardiology Division, Onassis Cardiac Surgery Center, Athens, Greece; and Vasilios...

Video

The TAVR Heart Team in 2026: Navigating the CMS Decision | A CTSNet Webinar

September 18, 2026 | Tom C. NguyenSilver Contributor…

CTSNet hosted a webinar on September 15, 2026, titled “The TAVR Heart Team in 2026: Navigating the CMS Decision,” featuring leading surgeons Tom B. Nguyen, Michael Mack, and Tsuyoshi Kaneko,...

Podcast

The Beat With Joel Dunning Ep. 174: Surgical Treatment of Atrial Fibrillation

September 17, 2026 | Joel DunningGold ContributorSilver Commentor…

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with James Cox, Professor of Cardiac Surgery at the Feinberg School of Medicine at Northwestern Medicine in Chicago, Illinois, USA,...

Podcast

The Beat With Joel Dunning Ep. 173: Uniportal Robotics in the UAE

September 10, 2026 | Joel DunningGold ContributorSilver Commentor

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Taj Mohammed Fiyaz Chowdhry, a consultant thoracic surgeon at Burjeel Specialty Hospital, Sharjah, UAE, about uniportal robotics in the...

JANS Article

The STS Risk Model for SAVR After TAVR

September 10, 2026 | Shrikar Modukuri

This study developed and validated an updated Society of Thoracic Surgeons (STS) risk model for surgical aortic valve replacement after a failed transcatheter aortic valve replacement (SAVR-after-TAVR), including the emergent...

JANS Article

Foldax Announces Successful First Human Use of Tria Biopolymer Mitral Heart Valve

June 4, 2021 | Wei-Guo Ma

On May 25, 2021, Dr. David Heimansohn successfully performed the first surgical implantation of biopolymer Tria™ heart valve in a patient with mitral valve disease at Ascension St. Vincent Hospital,...

JANS Article

The International Society for Minimally Invasive Cardiothoracic Surgery Expert Consensus Statement on Transcatheter and Surgical Aortic Valve Replacement in Low- and Intermediate-Risk Patients: A Meta-Analysis of Randomized and Propensity-Matched Studies

February 21, 2021 | Jessica Luc

In this article, Thourani et al present the International Society for Minimally Invasive Cardiothoracic Surgery Expert Consensus Statement on transcatheter and surgical aortic valve replacement in low- and intermediate-risk patients:...

JANS Article

Training the Trainee in Structural Heart Disease: A Need for Change

February 21, 2021 | Jessica Luc

In this article, Kilcoyne et al discuss the current status of training cardiothoracic surgery trainees in structural heart disease and propose a new core curriculum for training surgeons in structural...

JANS Article

Reoperation After Transcatheter Aortic Valve Replacement: An Analysis of the Society of Thoracic Surgeons Database

June 11, 2020 | Emily FarkasBronze Contributor

As TAVR is used in progressively lower-risk cohorts, management of device failure will become increasingly important. This study reports the largest series of patients receiving a surgical reoperation after transcatheter...

JANS Article

Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement

February 26, 2020 | Mark FergusonBronze Contributor

Five year results of the PARTNER II trial demonstrated no difference in the risk of stroke or death comparing TAVR to surgical aortic valve replacement among intermediate surgical risk patients....

JANS Article

Reduced Leaflet Motion After Transcatheter Aortic Valve Replacement

November 22, 2019 | Aristotle ProtopapasGold Commentor

Puzzling subgroup from the GALILEO trial, which appears in the same issue of the periodical as an article that discredits the use of rivaroxaban as thromboprevention strategy : https://www.nejm.org/doi/full/10.1056/NEJMoa1911425?query=recirc_curatedRelated_article, And...

JANS Article

Prosthetic Valve Endocarditis after TAVR and SAVR: Insights from the PARTNER Trials

November 7, 2019 | Mark FergusonBronze Contributor

Data from the PARTNER trials were assessed regarding post-procedural prosthetic valve endocarditis (PVE) after transcatheter aortic valve replacement and surgical aortic valve replacement. The timing and rates of PVE were...

JANS Article

Miscategorization of Deaths in the US Food and Drug Administration Adverse Events Database

October 10, 2019 | Mark FergusonBronze Contributor

Reporting of postmarket outcomes for the Sapien 3 and Mitraclip devices frequently misclassified patient deaths as device malfunction or other outcomes. Misclassification for Sapien 3 involved 17.5% of patient deaths,...

LOAD MORE
ADVERTISE ON CTSNET